Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 48 No. 3, 2018 - Full Issue Stacked PDF
1
x
$
90.00
Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach
1
x
$
30.00
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
1
x
$
30.00
View Cart
Checkout
Home
Antipsychotic Induced Symptomatic Hyperprolactinemia
“Treatment with Olanzapine: Early Predictors of Weight Gain Risk” has been added to your cart.
View cart
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Antipsychotic Induced Symptomatic Hyperprolactinemia quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-44-3-unax
Categories:
Psychopharmacology Bulletin
,
VOL 44 No. 3 Articles
Tags:
antipsychotic
,
bromocriptine
,
cabergoline
,
hyperprolactinemia
,
javier-peral
,
medworks-media
,
montserrat-garcia
,
pharmacovigilance
,
psychopharmacology-bulletin
,
saioa-domingo-echaburu
,
unax-lertxundi
,
volume-44
Description
Description
GENERAL PSYCHIATRY
Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?
Unax Lertxundi, Saioa Domingo-Echaburu, Javier Peral, Montserrat García
PB-44-3-2011-Unax
Related products
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Page load link
Go to Top
